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Until around 1990, most people were comfortable with the
notion that sunscreens that absorb or ¢lter out UVB (280^320 nm)
radiation provide adequate protection against sunburn in humans
and, by inference, against skin cancer as well. That UVB sun-
screens protect against erythema is not a point of controversy,
since they are tested and standardized for their ability to prevent
UV solar simulator-induced erythema in human skin. Certain
studies in mice support the inference that protection from er-
ythema also protects against skin cancer development. These in-
clude studies showing that sunscreens that block UVB radiation
could protect against skin cancers (Bestak and Halliday, 1996), as
well as mutation in the p53 gene (Aanthaswamy et al, 1997),
which play a critical role in the development of precancerous
lesions and skin cancers in both mice and in humans (Brash et al,
1991). Additionally, studies using hairless mice suggested that the
action spectrum (wavelength dependence) for carcinogenesis
approximated that for erythema (de Gruijl et al, 1993).
Beginning in the 1990s, however, researchers began to question
the assumption that erythema was the appropriate surrogate mar-
ker for skin cancer development when it came to sunscreen use.
This skepticism arose from reports that UVB sunscreens appeared
to be relatively ine¡ective in protecting against the immunosup-
pressive e¡ects of UV radiation (Ullrich et al, 1999), which are
thought to play a major facilitating role in UV carcinogenesis
(Fisher and Kripke, 1982). In this issue, Poon et al (p. 184) demon-
strate that, indeed, protection against UVA (320^400 nm) radia-
tion, in addition to UVB, plays an important role in mitigating at
least one immunosuppressive e¡ect of solar simulated UV radia-
tion in humans. Their study is unique in that they performed
dose^response studies to determine both the sun protection factor
(SPF) and immune protection factor (IPF) for several commer-
cially available sunscreen products in human subjects exposed to
a UV solar simulator. This provides a rigorous comparison of the
SPF and IPF in the same individuals, using the same light source
and standardized conditions. Interestingly, they found that the
IPF of a sunscreen showed a strong correlation with its ability to
protect against UVA radiation and no correlation with SPF. They
interpret their results as suggesting that it would be prudent to
include UVA absorbers in sunscreens, along with UVB absorbers
if protection against skin cancer is the desired e¡ect of their use.
Based on these and other studies demonstrating that wave-
lengths in the UVA region contribute to UV-induced immune
suppression (Nghiem et al, 2001), this seems an appropriate
admonition at present. However, much remains to be learned
regarding both the role of immune suppression in UV carcino-
genesis and the role of various UV wavelengths in the induction
of various types of skin cancer. With regard to the role of im-
mune suppression in carcinogenesis, there is at present no evi-
dence in mice or humans that UVA-induced immune
suppression contributes to UV carcinogenesis. The original de-
monstration of the role of UV-induced immune suppression in
UV carcinogenesis in mice (Fisher and Kripke, 1982) used tumor
rejection as a measure of immune suppression. Studies de¢ning
the UV wavelengths involved in this form of immune suppres-
sion ruled in the involvement of UVB wavelengths, but did
not examine a possible added contribution of UVA to the
UVB-mediated e¡ect (De Fabo and Kripke, 1980). Subsequent in-
vestigations of the immunosuppressive e¡ects of UV radiation
demonstrated that many measures of immune suppression are
evident after exposure of mice and humans to UV radiation.
These include alterations of Langerhans cell appearance and func-
tion, inhibition of the induction of contact and delayed-type hy-
persensitivity responses, elicitation of contact and delayed-type
hypersensitivity responses, and decreased resistance to infectious
diseases (Beissert and Schwarz, 1999). However, it remains unclear
which of these measures, if any, provides an appropriate surrogate
marker of tumor rejection.Thus, the most important question yet
to be resolved is whether UVA radiation contributes to the inhi-
bition of tumor immunity, which is the form of immune sup-
pression known to be relevant to carcinogenesis. In addition, it
would be helpful to know more about the wavelengths of UV
involved in reducing resistance to infectious diseases, since this
may also be of practical bene¢t in the design of sunscreens. Ulti-
mately, relevant, empirical studies are needed to answer these
questions. Studies on the mechanisms of UV-induced immune
suppression, while important, have not provided much insight
into the e⁄cacy of sunscreen use. The reason for this is the great
complexity of molecular perturbations caused by UV radiation
and the fact that action spectra for biological e¡ects of UV do
not fall neatly into our de¢nitions of UVA, B, and C wavelength
regions. In fact, it is possible, and even likely, that the mechanism
of a particular form of UV-induced immune suppression changes
with wavelength. For example, at wavelengths in the UVB and
UVC ranges, DNA damage may be the predominant initiator of
an immunosuppressive e¡ect, whereas at longer wavelengths, iso-
merization of urocanic acid and oxidative damage may give rise
to the same endpoint of immune suppression. Thus, empirical
testing of sunscreens against a series of endpoints is probably the
most practical and e¡ective approach for determining their e⁄-
cacy in preventing skin cancer and immune suppression.
With regard to the role of various wavelengths of UV in con-
tributing to the di¡erent types of human skin cancer, the situation
also remains somewhat murky.What is clear is that UVB radiation
is a key player in squamous cell carcinoma and a contributor to
basal cell carcinoma and probably also melanoma (de Gruijl et al,
2003). However, basal cell carcinoma and melanoma seem to have
a di¡erent relationship to UVB exposure than squamous cell carci-
noma. Thus, what is unclear is whether UVA plays a role in addi-
tion to UVB in any or all types of skin cancer and what other, as
yet unidenti¢ed, factors are important in the etiology of basal cell
carcinoma and melanoma.
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